福泰制药 VRTX 深 沪
已收盘 07-26 16:00:00 美东时间
495.26
+3.000
+0.61%
华盛通- 最 高502.97
- 今 开493.14
- 成交量 77.41万股
- 最 低 492.165
- 昨 收 492.26
- 总市值 1277.77亿
- 52周最高 503.99
- 市盈率 静 35.64
- 换手率 0.30%
- 52周最低 340.20
- 委 比 13.97%
- 总股本 2.58亿
- 历史最高 503.99
- 量 比 0.71
- 振 幅 2.19%
- 历史最低 26.50
- 每 手 1
- 风险率 45.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Needham Reiterates Hold on Vertex Pharmaceuticals
Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Hold.
07-26 17:35
Actinium wins FDA nod to conduct clinical trial for radiotherapy
Actinium Pharmaceuticals (NYSE:ATNM) announced Thursday that the U.S. FDA greenlighted an Investigational New Drug (IND) filed to request its clearance to conduct a clinical trial for the company's ra...
07-25 22:29
Albemarle is out of Wells Fargo’s Signature Picks
Wells Fargo analysts updated their “Signature Picks” and removed Albemarle (ALB) from the portfolio after a downgrade. The portfolio has a year-to-date performance of 19.5%, outperforming the S&P 500 ...
07-24 22:43
快讯 | Vertex制药公司：TD Cowen将目标价从450美元上调至500美元。
Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $500 From $450
07-23 19:57
Cantor Fitzgerald Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $480
Cantor Fitzgerald analyst Olivia Brayer maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target from $440 to $480.
07-22 23:36
快讯 | Vertex Pharmaceuticals公司: H.C. Wainwright将目标价从462美元上调至500美元
Vertex Pharmaceuticals Inc. : H.c. Wainwright Raises Target Price to $500 From ...
07-19 18:06
快讯 | Vertex Pharmaceuticals公司：JP Morgan将目标价从450美元提高至505美元。
Vertex Pharmaceuticals Inc : JP Morgan Raises Target Price to $505 From $450
07-19 12:24
Genomics Extends And Expansion Drug Discovery Collaboration With Vertex
- Three-year extension of collaboration to use genomics to accelerate drug discovery - - The range of therapeutic areas and genomic data insights will be expanded and the companies will also explore using genomic
07-16 21:15
